Prenatal Endocrine Organization and Gender Development: Human Natural Experiments, Steroid Signaling, and the Limits of Hormonal Determinism

Developmental sex-steroid signaling is fundamental to human sexual differentiation. Whether variation in that signaling contributes to later gender identity and persistent gender incongruence is a substantially more difficult question. Evidence from congenital adrenal hyperplasia (CAH), androgen-insensitivity syndromes, 5α-reductase type 2 deficiency, 17β-hydroxysteroid dehydrogenase type 3 deficiency, prospective hormone studies, and behavioral endocrinology provides natural and quasi-natural experiments through which components of this question can be investigated. The resulting evidence does not support either endocrine irrelevance or hormonal determinism. Prenatal androgen excess in females with classical CAH produces substantial average shifts in several gender-typed activities and interests. Effects on gender identity are considerably smaller and less uniform. Complete androgen insensitivity syndrome demonstrates that circulating androgen production and effective androgen signaling are biologically distinct, while 5α-reductase deficiency and related differences of sex development demonstrate that major alterations of steroid synthesis or metabolism can change distributions of later gender outcomes without producing uniform identities. Across disorders/differences of sex development (DSDs), extreme between-condition and between-study heterogeneity argues against treating DSDs as a single endocrine experiment. This paper develops a temporally and biologically resolved model of effective developmental steroid signaling and distinguishes fetal development, minipuberty, and puberty rather than collapsing these into a single exposure. Four methodological concepts are developed: the Endocrine Phenotype Specificity Principle, the Developmental Endocrine Dissociation Framework, the Endocrine Non-Determinism Constraint, and an Exposure × Phenotype Attenuation Model. The current evidence supports a graded conclusion: developmental steroid signaling clearly organizes human sexual differentiation and influences some later sex-differentiated behaviors; it may alter probabilities of some later gender-identity outcomes; but no specific prenatal endocrine mechanism has been established as necessary or sufficient for persistent gender incongruence. Future research requires prospective endocrine measurement, genetically resolved natural experiments, deep longitudinal gender phenotyping, gene-by-endocrine analyses, and explicit falsification criteria.